BPA Call W90VN621A0006-W90VN625F5001
Award Date 10/1/24
Potential Completion Date 2/28/26
Potential Value $984
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Propath Services, LLC, a nationwide pathology practice that provides patient-centered medical diagnostics, prognostic assessments, and related services. The contract is for $125,000.00 and is for specialized laboratory studies and tests. This award is not a set-aside. Propath Services has previously provided services such as immunochemistry stains analysis, interpretation services, dermatopathology diagnostic...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a firm-fixed price purchase order contract valued at $21,343.89 to the College of American Pathologists for laboratory proficiency testing services. The contract calls for the prime contractor to provide biannual proficiency testing programs covering all areas of clinical pathology and anatomical pathology to approximately 50-75 users at the VA Long Beach Healthcare System located...
- Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $94,000 firm fixed price delivery order contract to provide ThyroSeq cancer tests to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. Under this contract, Cblpath will deliver 60 ThyroSeq cancer tests per month for 12 months to support medical services for veterans in the Port Chester, New York area. No set-aside designation was applied to this award made using the...
- Cytopathology & Thyrosequence Testing Service Option Year 1 was awarded to Cytopath Biopsy Lab Inc. on October 1, 2022 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The firm fixed price delivery order, valued at $35,045, calls for cytopathology and thyrosequence testing services to be provided to the agency through September 30, 2023. Place of performance will be in Northport, New York. No set aside designation was applied to this...
- Toxicologic Pathology Associates Inc. (UEI: PMMBWH3UHBV7) was awarded a definitive contract by the Food and Drug Administration (FDA) on July 14, 2020, to provide on-site pathology services. This labor-hours contract, designated as a Total Small Business set-aside, carries a ceiling value of $24.58 million and is slated for completion by September 15, 2025. The services will be performed at the FDA facility located in Jefferson, Arkansas. Pathology services of this nature typically support the...
- The U.S. Department of the Navy, Bureau of Medicine and Surgery awarded a $87,940.80 firm fixed price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for "THROSEQ V.2 GENETIC MAIL OUT TESTING" and "SPRIOCHETE GENETIC MAIL OUT TESTING" services. The contract has a period of performance from June 25, 2019 to September 30, 2020. This procurement was conducted on an unrestricted, full and open competition basis and was not set aside for any special...
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a firm fixed-price purchase order valued at $2.31M to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for ThyroSeq molecular diagnostic testing services. Under this contract, Cblpath will provide approximately 225 tests annually to multiple VA healthcare facilities within VISN 22, with interpretive reports to be delivered within 14 days of testing. The ThyroSeq test analyzes genetic mutations in thyroid...
- Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $12,000 firm fixed price delivery order contract for cytopathology and ThyroSeq testing services. The contract is associated with the Department of Veterans Affairs Veterans Health Administration's Veterans Integrated Service Network 4 and has a period of performance through May 31, 2023. Under this contract, Cblpath will provide cytopathology laboratory testing and molecular diagnostic testing for thyroid cancer to...
- The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...
- This $64,400.00 firm fixed price delivery order was awarded to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The order is for cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs. Cblpath is a specialized anatomic pathology and molecular diagnostics laboratory that has previously provided ThyroSequence testing to the VA and Department of Defense...
- W90VN621A0006Blanket Purchase Agreement
- W90VN621A0006-W90VN625F5001BPA Call
PATHOLOGY TEST
Posted 10/31/24
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $984 | 10/31/24 |